DIAGENS-B
0252618AListed醫療健康 · 杭州德適生物科技股份有限公司是一家专注于生物科技领域的公司，主要从事相关产品的研发与销售。
High attention
78.5
/100
- Offer price
- HK$99.00
- Final offer price
- HK$99.00
- Lot / entry fee
- 50 shares · HK$5K
- Proceeds
- HK$791.9M
- Sponsor
- Huatai Financial
- Est. margin oversub.
- 708.7x
- Public oversub.
- 1073.4x
- One-lot win rate
- 3.0%
- First-day return
- +111.7%
Offer starts
Mar 20
Offer closes
Mar 25
Grey market
Mar 27
Listing
Mar 30
AI reference scoring and scenarios
After grey market
After grey market L1 heat score
78.5/ 100
Data coverage High
Target
Historical calibration
Listing-day trend
PositivePartial basis
Up probability
95.0%
First-day reference range
+74.6% – +160.4%
Published outcome check
First-day resultBig up+111.7%
Our call: Trend call valid
Covered 16/25 core factors
UsedMissingNot yet scorableN/A
Margin oversubscription
High heatOffer size
Good qualityCornerstone lockup
—Post-lockup offer value
—Recent same-rule trend
Neutral trendRecent same-type trend
Strong trendRecent sector trend
Strong trendValuation
Weak appealFundamental quality
Weak qualityGrowth quality
—Profitability
Weak qualityCash runway
High qualityCustomer concentration
High riskCornerstone quality
—Sponsor record
Good recordGreenshoe arrangementNo greenshoe
Stabilizer track record
—A-share pre-grey trend
—A-share listing-day trend
—Public oversubscription
High heatOne-lot win rate
Good heatInternational placing
High heatFinal pricing position
—Actual greenshoe use
—Grey market return
Strong trendThe assessment and probability ranges are informational only and are not investment advice.
AI Research Report
After grey marketThe analysis report for this IPO is being generated.